Antithrombin III deficiency and idiopathic intracranial hypertension: a case report

Abstract Background Idiopathic intracranial hypertension (IIH) is a condition where the pressure of the cerebrospinal fluid in the brain increases without a known cause. It typically affects adults but can also occur in adolescents and children, although it is less common. Numerous elements, includi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mansoureh Togha, Yousef Mokary, Elham Jafari
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Medical Case Reports
Subjects:
Online Access:https://doi.org/10.1186/s13256-024-04997-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850076037732368384
author Mansoureh Togha
Yousef Mokary
Elham Jafari
author_facet Mansoureh Togha
Yousef Mokary
Elham Jafari
author_sort Mansoureh Togha
collection DOAJ
description Abstract Background Idiopathic intracranial hypertension (IIH) is a condition where the pressure of the cerebrospinal fluid in the brain increases without a known cause. It typically affects adults but can also occur in adolescents and children, although it is less common. Numerous elements, including coagulopathy, have been documented in previous cases as potential etiological factors of IIH. Nonetheless, our objective was to present the insufficiency of a coagulation factor as an additional contributing factor to IIH, a notion that has not been previously reported. Case presentation In this case, a 34-year-old West Asian female patient presented with a subacute generalized headache, bilateral blurred vision, and papilledema. The patient’s brain magnetic resonance imaging showed flattening of the posterior globe and empty sella, but no other abnormalities were detected. The results of magnetic resonance venography and cerebrospinal fluid analysis were also normal, except for an opening cerebrospinal fluid pressure of 600 mm H2O during the lumbar puncture. Rheumatologic and endocrine disorders were ruled out on the basis of clinical assessment and laboratory tests. The patient was started on acetazolamide (1 g/day, increased to 2 g/day) and furosemide (20 mg/twice a day) and was encouraged to lose weight. These treatments led to some improvement for about 1 year, but her symptoms then worsened without an obvious cause. Given the prolonged duration of the disease and the lack of expected response to treatment, the patient was reevaluated for endocrinopathy and collagen vascular disease, which were negative. An additional workup revealed an antithrombin III (AT III) deficiency, for which the patient was prescribed acetylsalicylic acid (80 mg/day) in addition to the previous medications. As a result, the patient’s papilledema, macular thickness, and nerve fiber layer edema decreased, as observed by fundoscopy and optical coherence tomography. Clinical examination and imaging also showed improvement in the patient’s symptoms. Conclusion This case highlights the importance of considering coagulopathy in cases of IIH and suggests that antiplatelet therapy with acetylsalicylic acid may be beneficial for such patients.
format Article
id doaj-art-4a5ba576060e4aa5a503f2b288d37d99
institution DOAJ
issn 1752-1947
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Medical Case Reports
spelling doaj-art-4a5ba576060e4aa5a503f2b288d37d992025-08-20T02:46:07ZengBMCJournal of Medical Case Reports1752-19472025-01-011911610.1186/s13256-024-04997-zAntithrombin III deficiency and idiopathic intracranial hypertension: a case reportMansoureh Togha0Yousef Mokary1Elham Jafari2Neurology Department, Sina Hospital, School of Medicine, Tehran University of Medical SciencesStudent Research Committee, Shahrekord University of Medical SciencesHeadache Department, Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical SciencesAbstract Background Idiopathic intracranial hypertension (IIH) is a condition where the pressure of the cerebrospinal fluid in the brain increases without a known cause. It typically affects adults but can also occur in adolescents and children, although it is less common. Numerous elements, including coagulopathy, have been documented in previous cases as potential etiological factors of IIH. Nonetheless, our objective was to present the insufficiency of a coagulation factor as an additional contributing factor to IIH, a notion that has not been previously reported. Case presentation In this case, a 34-year-old West Asian female patient presented with a subacute generalized headache, bilateral blurred vision, and papilledema. The patient’s brain magnetic resonance imaging showed flattening of the posterior globe and empty sella, but no other abnormalities were detected. The results of magnetic resonance venography and cerebrospinal fluid analysis were also normal, except for an opening cerebrospinal fluid pressure of 600 mm H2O during the lumbar puncture. Rheumatologic and endocrine disorders were ruled out on the basis of clinical assessment and laboratory tests. The patient was started on acetazolamide (1 g/day, increased to 2 g/day) and furosemide (20 mg/twice a day) and was encouraged to lose weight. These treatments led to some improvement for about 1 year, but her symptoms then worsened without an obvious cause. Given the prolonged duration of the disease and the lack of expected response to treatment, the patient was reevaluated for endocrinopathy and collagen vascular disease, which were negative. An additional workup revealed an antithrombin III (AT III) deficiency, for which the patient was prescribed acetylsalicylic acid (80 mg/day) in addition to the previous medications. As a result, the patient’s papilledema, macular thickness, and nerve fiber layer edema decreased, as observed by fundoscopy and optical coherence tomography. Clinical examination and imaging also showed improvement in the patient’s symptoms. Conclusion This case highlights the importance of considering coagulopathy in cases of IIH and suggests that antiplatelet therapy with acetylsalicylic acid may be beneficial for such patients.https://doi.org/10.1186/s13256-024-04997-zAntithrombin III deficiencyHeadacheIdiopathic intracranial hypertensionPseudotumor cerebriPapilledema
spellingShingle Mansoureh Togha
Yousef Mokary
Elham Jafari
Antithrombin III deficiency and idiopathic intracranial hypertension: a case report
Journal of Medical Case Reports
Antithrombin III deficiency
Headache
Idiopathic intracranial hypertension
Pseudotumor cerebri
Papilledema
title Antithrombin III deficiency and idiopathic intracranial hypertension: a case report
title_full Antithrombin III deficiency and idiopathic intracranial hypertension: a case report
title_fullStr Antithrombin III deficiency and idiopathic intracranial hypertension: a case report
title_full_unstemmed Antithrombin III deficiency and idiopathic intracranial hypertension: a case report
title_short Antithrombin III deficiency and idiopathic intracranial hypertension: a case report
title_sort antithrombin iii deficiency and idiopathic intracranial hypertension a case report
topic Antithrombin III deficiency
Headache
Idiopathic intracranial hypertension
Pseudotumor cerebri
Papilledema
url https://doi.org/10.1186/s13256-024-04997-z
work_keys_str_mv AT mansourehtogha antithrombiniiideficiencyandidiopathicintracranialhypertensionacasereport
AT yousefmokary antithrombiniiideficiencyandidiopathicintracranialhypertensionacasereport
AT elhamjafari antithrombiniiideficiencyandidiopathicintracranialhypertensionacasereport